Related references
Note: Only part of the references are listed.Medical ovariectomy in menopausal breast cancer patients with high testosterone levels: a further step toward tailored therapy
Giorgio Secreto et al.
ENDOCRINE-RELATED CANCER (2017)
Associations of obesity and physical activity with serum and intratumoral sex steroid hormone levels among postmenopausal women with breast cancer: analysis of paired serum and tumor tissue samples
Yoichiro Kakugawa et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer
J. O'Shaughnessy et al.
ANNALS OF ONCOLOGY (2016)
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
H. Bonnefoi et al.
ANNALS OF ONCOLOGY (2016)
A novel approach to breast cancer prevention: reducing excessive ovarian androgen production in elderly women
Giorgio Secreto et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer
Andrew Ciupek et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort
Karin Elebro et al.
CLINICAL CANCER RESEARCH (2015)
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
Daniel A. Dumesic et al.
ENDOCRINE REVIEWS (2015)
Targeting the androgen receptor in prostate and breast cancer: several new agents in development
Tracy Proverbs-Singh et al.
ENDOCRINE-RELATED CANCER (2015)
Targeting the Androgen Receptor in Breast Cancer
KeeMing Chia et al.
CURRENT ONCOLOGY REPORTS (2015)
A Nationwide Population-Based Retrospective Cohort Study of the Risk of Uterine, Ovarian and Breast Cancer in Women With Polycystic Ovary Syndrome
Cheng-Che Shen et al.
ONCOLOGIST (2015)
Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes
Keely M. McNamara et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
AR collaborates with ERα in aromatase inhibitor-resistant breast cancer
Yassine Rechoum et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Complexities of androgen receptor signalling in breast cancer
Keely M. McNamara et al.
ENDOCRINE-RELATED CANCER (2014)
Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis
John A. Barry et al.
HUMAN REPRODUCTION UPDATE (2014)
Revising the role of the androgen receptor in breast cancer
F. M. Fioretti et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)
Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
Francisco E. Vera-Badillo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial
Jack Cuzick et al.
LANCET (2014)
The role of androgens in experimental rodent mammary carcinogenesis
Jaesung Choi et al.
BREAST CANCER RESEARCH (2014)
Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism
Toru Hanamura et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study
H. Iwase et al.
BRITISH JOURNAL OF CANCER (2013)
Androgenic pathway in triple negative invasive ductal tumors: Its correlation with tumor cell proliferation
Keely M. McNamara et al.
CANCER SCIENCE (2013)
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
Richard S. Legro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data
Jack Cuzick et al.
LANCET (2013)
Development of the Human Breast
Asma Javed et al.
SEMINARS IN PLASTIC SURGERY (2013)
The Androgen Receptor in Breast Tissues: Growth Inhibitor, Tumor Suppressor, Oncogene?
T. E. Hickey et al.
MOLECULAR ENDOCRINOLOGY (2012)
Mechanisms of Endocrine Resistance in Breast Cancer
C. Kent Osborne et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Estrogens in the breast tissue: a systematic review
Lusine Yaghjyan et al.
CANCER CAUSES & CONTROL (2011)
Sex Hormone Concentrations and the Risk of Breast Cancer Recurrence in Postmenopausal Women without Hot Flashes
Jennifer A. Emond et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
Rong Hu et al.
CLINICAL CANCER RESEARCH (2011)
Differential Effects of Exogenous Androgen and an Androgen Receptor Antagonist in the Peri- and Postpubertal Murine Mammary Gland
A. A. Peters et al.
ENDOCRINOLOGY (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Paul E. Goss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional study
Giorgio Secreto et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2011)
The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo
Jodie M. Fleming et al.
BMC MEDICINE (2010)
Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells
Francesca De Amicis et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Prevalence of Tamoxifen Use for Breast Cancer Chemoprevention Among US Women
Erika A. Waters et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Fertility in Women with Nonclassical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Maud Bidet et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Patient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis
Mary E. Ropka et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
Leo A. Niemeier et al.
MODERN PATHOLOGY (2010)
EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast
Semir Vranic et al.
MODERN PATHOLOGY (2010)
Aromatase over expression transgenic murine models for aromatase inhibitor studies
Xiangdong Li
MOLECULAR HUMAN REPRODUCTION (2010)
Androgens in human breast carcinoma
Takashi Suzuki et al.
MEDICAL MOLECULAR MORPHOLOGY (2010)
New Developments in Intracrinology of Human Breast Cancer Estrogen Sulfatase and Sulfotransferase
Hironobu Sasano et al.
STEROID ENZYMES AND CANCER (2009)
17 beta-Hydroxysteroid Dehydrogenases in Human Breast Cancer
Shuji Nagasaki et al.
STEROID ENZYMES AND CANCER (2009)
The androgen metabolite 5α-androstane-3β,17β-diol (3βAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance
Matthew J. Sikora et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Testosterone and Biological Characteristics of Breast Cancers in Postmenopausal Women
Giorgio Secreto et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Androgen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer
Amelia A. Peters et al.
CANCER RESEARCH (2009)
History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target
R. J. Santen et al.
ENDOCRINE REVIEWS (2009)
In situ estrogen production and its regulation in human breast carcinoma: From endocrinology to intracrinology
Hironobu Sasano et al.
PATHOLOGY INTERNATIONAL (2009)
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function
Suleiman Massarweh et al.
CANCER RESEARCH (2008)
The epidermal growth factor receptor family: Biology driving targeted therapeutics
M. J. Wieduwilt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype
Maggie C. U. Cheang et al.
CLINICAL CANCER RESEARCH (2008)
Aromatase in human breast carcinoma as a key regulator of intratumoral sex steroid concentrations
Takashi Suzuki et al.
ENDOCRINE JOURNAL (2008)
Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast
Rie Shibuya et al.
ENDOCRINE-RELATED CANCER (2008)
A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer
Ali Naderi et al.
NEOPLASIA (2008)
Plasma testosterone and prognosis of postmenopausal breast cancer patients
Andrea Micheli et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prognostic markers in triple-negative breast cancer
Emad A. Rakha et al.
CANCER (2007)
Extensive clinical experience - Nonclassical 21-hydroxylase deficiency
Maria I. New
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline
Ricardo Azziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen
A. S. Doane et al.
ONCOGENE (2006)
Identification of molecular apocrine breast tumours by microarray analysis
P Farmer et al.
ONCOGENE (2005)
Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: A long-term prospective study
SR Cummings et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Regulation of aromatase expression in estrogen-responsive breast and uterine disease: From bench to treatment
SE Bulun et al.
PHARMACOLOGICAL REVIEWS (2005)
Serum testosterone levels and breast cancer recurrence
F Berrino et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Multiple structural and functional abnormalities in the P450 aromatase expressing transgenic male mice are ameliorated by a P450 aromatase inhibitor
XD Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women
SA Missmer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Ovarian stromal hyperplasia and ovarian vein steroid levels in relation to endometrioid endometrial cancer
VHWM Jongen et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2003)
Host microenvironment in breast cancer development - Extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast
MPV Shekhar et al.
BREAST CANCER RESEARCH (2003)
The mammary gland and its origin during synapsid evolution
OT Oftedal
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2002)
Roles of androgens in the development, growth, and carcinogenesis of the mammary gland
DJ Liao et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
Hormone/growth factor interactions mediating epithelial/stromal communication in mammary gland development and carcinogenesis
W Imagawa et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
Polycystic ovary syndrome and cancer
A Balen
HUMAN REPRODUCTION UPDATE (2001)
Share Paper
